Skip to content
Clinical Trials – home
DenmarkBack to Denmark

Clinical trials in Frederiksberg

30 clinical trials in Frederiksberg, Denmark across 1 research site. Every trial is listed in the EU Clinical Trials Register and updated daily.

DenmarkOur site in DenmarkKliniske-Forsoeg.dk(opens in a new tab)
Frederiksberg at a glance
30
clinical trials
  • Paediatric trials0
  • Research sites1
Type of trial
Recruitment status
Quick filters

30 trials in Frederiksberg

Open in trial search
Countries:DenmarkDenmark
  • Participants:18–64 years · 65+ years
  • Sponsor:Novo Nordisk A/S
Countries:DenmarkDenmark
  • Participants:18–64 years · 65+ years
  • Sponsor:AstraZeneca AB
Countries:DenmarkDenmark
  • Participants:18–64 years · 65+ years
  • Substances:Maridebart Cafraglutide
  • Sponsor:Amgen Inc.
Countries:DenmarkDenmark
  • Participants:18–64 years · 65+ years
  • Substances:Baxdrostat
  • Sponsor:AstraZeneca AB
Countries:DenmarkDenmark
  • Participants:18–64 years · 65+ years
  • Substances:Ro7790121
  • Sponsor:F. Hoffmann-La Roche AG
Registered drug
Countries:DenmarkDenmark
  • Participants:18–64 years · 65+ years
  • Substances:Colchicine
  • Sponsor:Region Hovedstaden
Countries:DenmarkDenmark
  • Participants:18–64 years · 65+ years
  • Sponsor:Novo Nordisk A/S

Drug dependence

Recruiting
Registered drug
Countries:DenmarkDenmark
  • Participants:18–64 years · 65+ years
  • Substances:Semaglutide
  • Sponsor:Region Hovedstaden
Countries:DenmarkDenmark
  • Participants:18–64 years · 65+ years
  • Sponsor:Amgen Inc.
Countries:DenmarkDenmark
  • Participants:18–64 years · 65+ years
  • Sponsor:Region Hovedstaden
Countries:DenmarkDenmark
  • Participants:18–64 years · 65+ years
  • Substances:Ferric Derisomaltose
  • Sponsor:Pharmacosmos A/S

Other cities in Denmark

The busiest research cities in the country

All 47 cities in Denmark

Clinical research in Frederiksberg

What the registry says about research in the country

01 Cardiovascular Research

Groundbreaking studies focusing on heart failure prevention and innovative treatments for hypertrophic cardiomyopathy. Research includes evaluation of new medications for stroke prevention in patients with atrial fibrillation.

  • Heart Failure Prevention Studies
  • Atrial Fibrillation Management
  • Cardiac Structure Assessment

Novel therapeutic approaches are being tested to reduce cardiovascular events and improve patient outcomes.

02 Rheumatology Studies

Comprehensive research into psoriatic arthritis treatments, including multiple trials testing biological therapies and innovative medications for both biologic-experienced and biologic-naïve patients.

  • Psoriatic Arthritis Treatments
  • Axial Spondyloarthritis Research
  • Inflammatory Disease Management

Studies focus on reducing symptoms and improving quality of life for patients with inflammatory joint conditions.

03 Metabolic Disorders

Advanced research targeting severe hypertriglyceridemia and metabolic conditions. Studies evaluate new therapeutic options and their effectiveness in managing lipid disorders.

  • Lipid Management Therapies
  • Metabolic Disease Treatment
  • Cardiovascular Risk Reduction

Innovative approaches are being investigated to address complex metabolic conditions and their complications.

04 Psychiatric Medicine

Pioneering research examining treatments for alcohol use disorder with concurrent conditions, including studies on innovative therapeutic approaches for patients with schizophrenia.

  • Dual Diagnosis Treatment
  • Addiction Management
  • Mental Health Interventions

Research focuses on developing integrated treatment approaches for complex psychiatric conditions.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.